Drs. Berrocal Reflect on ASRS 2026 - Summary - MDSpire
Advertisement
Drs. Berrocal Reflect on ASRS 2026
ASRS 2026 meeting program chair Audina M. “Nina” Berrocal, MD, FASRS, joins Maria H. Berrocal, MD, to discuss the meeting’s highlights, surgical sessions, and educational approach.
To discuss the highlights and innovative aspects of the 44th Annual ASRS meeting, including the focus on diversity and interactive discussions.
Approach:
Meeting Overview: Drs. Audina M. Berrocal and Maria H. Berrocal reflect on the ASRS 2026 meeting, noting its innovative format and diversity, with a focus on younger and female surgeons.
Surgical Sessions: The meeting featured a session titled 'Retina Surgery Around the Globe,' showcasing outstanding surgeries by young surgeons from various countries, which was highlighted as a favorite by attendees.
Discussion Format: The meeting adopted a short talk format followed by robust discussions, which was well-received by attendees, emphasizing the value of interactive learning.
Diversity Focus: There was a notable emphasis on including women and young surgeons in presentations, contributing to a fresh and vibrant atmosphere, as expressed by the speakers.
Key Findings:
The meeting highlighted the contributions of young and diverse surgeons, as emphasized by the speakers.
The format encouraged discussions that enhanced learning, which was a key point made by Dr. Maria Berrocal.
The inclusion of international perspectives enriched the program, as noted during the discussions.
Interpretation:
The ASRS 2026 meeting successfully integrated innovative approaches and diverse representation, fostering an engaging learning environment.
Conclusion:
The ASRS 2026 meeting was characterized by its focus on diversity and interactive discussions, reflecting the speakers' commitment to evolving the field of retina surgery.
Data from a retrospective Emory Eye Center series suggest most eyes with CME following infectious retinitis achieved resolution without disease reactivation, although prolonged treatment and close monitoring were often required.
At OIS Retina in Montreal, Riad Sherif, MD, discussed Oculis’s optic neuritis program and why neuroprotection may represent the next frontier in retinal therapeutics.
